nach oben

Indian Journal of Otolaryngology and Head & Neck Surgery

Erschienen in:

14.08.2023 | Original Article

Diagnostic Utility of Expression Pattern of S100/Mammaglobin/SOX10/DOG 1 Immunohistochemistry in Differentiation of Secretory and Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis

verfasst von: Gitika Sharma, Mala Kamboj, Anjali Narwal, R. Keerthika, Anju Devi, Gopikrishnan Vijayakumar

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Secretory carcinoma (SC) is a relatively new disease entity, separate from acinic cell carcinoma (AciCC), which frequently displays ETV6-NTRK3 gene fusion. However, the differences between SC and AciCC remain ambiguous. Genetic diversity makes its diagnosis complicated. In this regard combined expression of immunohistochemistry markers S100/Mammaglobin/SOX10 and DOG1 is need of the hour as alternative methodology. The current systematic review was to investigate the diagnostic utility of combined immunohistochemical expression of S100/Mammaglobin/SOX10/DOG1 in distinction of SC from AciCC histologically. An electronic search of databases was carried out using MEDLINE by PubMed, Google scholar, Scopus and Web of science. Articles inclusive of SC and AciCC were assessed with S100/Mammaglobin/SOX10/DOG1 immunohistochemistry and their predominant expression pattern, predictive values, sensitivity and specificity were gathered. Fourteen eligible articles were analysed, which revealed predominant immunostaining pattern of S100 + /Mammaglobin + /SOX10 + /DOG1- by nearly all ETV6::NTRK3 fusion prevalent SCs alongside with other gene fusions like RET, MET and MAML3 with 98.4% sensitivity as well as 86.1% specificity. The evidence supports that S100/Mammaglobin/SOX10/DOG1 combined immunostaining can serve as a reliable diagnostic method to differentiate secretory from acinic cell carcinoma.

Son E, Panwar A, Mosher CH, Lydiatt D (2018) Cancers of the major salivary gland. J Oncol Pract 14(2):99–108. https://doi.org/10.1200/JOP.2017.026856. (PMID: 29436307)CrossRefPubMed

Skalova A, Bell D, Bishop JA, Inagaki H, Seethala R, Vielh P (2017) Secretory carcinoma. In: El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ (eds) WHO classifcation of head and neck tumours. International Agency for Research on Cancer, Lyon, pp 177–178

Chiosea SI, Griffith C, Assaad A, Seethala RR (2012) The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol 36(3):343–350. https://doi.org/10.1097/PAS.0b013e318242a5b0. (PMID: 22301503)CrossRefPubMed

Skálová A, Vanecek T, Simpson RH, Laco J, Majewska H, Baneckova M, Steiner P, Michal M (2016) Mammary analogue secretory carcinoma of salivary glands: molecular analysis of 25 ETV6 gene rearranged tumors with lack of detection of classical ETV6-NTRK3 fusion transcript by standard RT-PCR: report of 4 cases Harboring ETV6-X gene fusion. Am J Surg Pathol 40(1):3–13. https://doi.org/10.1097/PAS.0000000000000537. (PMID: 26492182)CrossRefPubMed

Rooper LM, Karantanos T, Ning Y, Bishop JA, Gordon SW, Kang H (2018) Salivary secretory carcinoma with a novel ETV6-MET fusion: expanding the molecular spectrum of a recently described entity. Am J Surg Pathol 42(8):1121–1126. https://doi.org/10.1097/PAS.0000000000001065. (PMID: 29683815)CrossRefPubMed

Andreasen S, Kiss K, Melchior LC, Laco J (2018) The ETV6-RET gene fusion is found in ETV6-rearranged low-grade sinonasal adenocarcinoma without NTRK3 involvement. Am J Surg Pathol 42(7):985–988. https://doi.org/10.1097/PAS.0000000000001069. (PMID: 29683817)CrossRefPubMed

Skalova A, Vanecek T, Martinek P, Weinreb I, Stevens TM, Simpson RHW, Hyrcza M, Rupp NJ, Baneckova M, Michal M Jr, Slouka D, Svoboda T, Metelkova A, Etebarian A, Pavelka J, Potts SJ, Christiansen J, Steiner P, Michal M (2018) Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol 42(2):234–246. https://doi.org/10.1097/PAS.0000000000000972. (PMID: 29076873)CrossRefPubMed

Ni H, Zhang XP, Wang XT, Xia QY, Lv JH, Wang X, Shi SS, Li R, Zhou XJ, Rao Q (2016) Extended immunologic and genetic lineage of mammary analogue secretory carcinoma of salivary glands. Hum Pathol 58:97–104. https://doi.org/10.1016/j.humpath.2016.09.001. (Epub 2016 Sep 19 PMID: 27658560)CrossRefPubMed

Baghai F, Yazdani F, Etebarian A, Garajei A, Skalova A (2017) Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin. Pathol Res Pract 213(9):1112–1118. https://doi.org/10.1016/j.prp.2017.07.017. (Epub 2017 Jul 23 PMID: 28781197)CrossRefPubMed

10.

Khurram SA, Sultan-Khan J, Atkey N, Speight PM (2016) Cytogenetic and immunohistochemical characterization of mammary analogue secretory carcinoma of salivary glands. Oral Surg Oral Med Oral Pathol Oral Radiol 122(6):731–742. https://doi.org/10.1016/j.oooo.2016.07.008. (Epub 2016 Jul 20 PMID: 27720350)CrossRefPubMed

11.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group PRISMA (2009) Preferred reporting items for systematic reviews and meta- analyses: the PRISMA statement. PLoS Med 21:e1000097CrossRef

12.

Li YH, Basheeth N, Kumar A (2021) Mammary analogue secretory carcinoma (MASC): a literature review and report of two cases. J Clin Images Med Case Rep 2(6):1446CrossRef

13.

Karabachev A, Aulet R, Sajisevi M, Ciolino A (2020) A case of secretory carcinoma of the submandibular gland with unusual immunohistochemical staining. Clin Case Rep 8(8):1530–1533. https://doi.org/10.1002/ccr3.2927.PMID:32884789;PMCID:PMC7455405CrossRefPubMedPubMedCentral

14.

Urano M, Nagao T, Miyabe S, Ishibashi K, Higuchi K, Kuroda M (2015) Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers. Hum Pathol 46(1):94–103. https://doi.org/10.1016/j.humpath.2014.09.012. (Epub 2014 Oct 7 PMID: 25456394)CrossRefPubMed

15.

Uy TC, Isa AH, Carnarte J (2022) Secretory carcinoma of the salivary glands. Philipp J Otolaryngol Head Neck Surg 37(1):59CrossRef

16.

Kallarakkal TG, Ismail SM, Goh YC (2022) Zymogen-poor acinic cell carcinoma of the soft palate with high-grade transformation. Malays J Pathol 44(1):121–127 (PMID: 35484895)PubMed

17.

Woo WY, Sutton R, Arachchi A, Singh S, Ghali M (2017) Mammary analogue secretory carcinoma of the parotid gland–a case report. Pathology 49:S92CrossRef

18.

Shibata E, Morita KI, Kayamori K, Maruiwa M, Michi Y, Sato Y, Takeuchi K, Ikeda T, Harada H, Yoda T (2020) Secretory carcinoma around Stensen’s duct misdiagnosed as salivary duct cyst. Int J Clin Exp Pathol 13(8):2211–2217 (PMID: 32922622; PMCID: PMC7476943)PubMedPubMedCentral

19.

Baneckova M, Agaimy A, Andreasen S, Vanecek T, Steiner P, Slouka D, Svoboda T, Miesbauerova M, Michal M Jr, Skálová A (2018) Mammary analog secretory carcinoma of the nasal cavity: characterization of 2 cases and their distinction from other low-grade sinonasal adenocarcinomas. Am J Surg Pathol 42(6):735–743. https://doi.org/10.1097/PAS.0000000000001048. (PMID: 29543674)CrossRefPubMed

20.

AlKaabba F, Alloghbi A, Deajim Y, Sukkari MW, Khan MYA, Sukari A (2022) NTRK3 mutation in secretory carcinoma of the parotid gland: a case report. Clin Case Rep 10(9):e6243. https://doi.org/10.1002/ccr3.6243. (PMID: 36093449; PMCID: PMC9445263)CrossRefPubMedPubMedCentral

21.

Wiles AB, Gabrielson M, Baloch ZW, Faquin WC, Jo VY, Callegari F, Kholova I, Song S, Centeno BA, Ali SZ, Tommola S, Fadda G, Petrone G, Wang H, Rossi ED, Pantanowitz L, Maleki Z (2022) Secretory carcinoma of the salivary gland, a rare entity: an international multi-institutional study. Cancer Cytopathol 130(9):684–694. https://doi.org/10.1002/cncy.22574. (Epub 2022 Apr 6. PMID: 35385604; PMCID: PMC9545582)CrossRefPubMedPubMedCentral

22.

Wu B, Loh TKS, Vanecek T, Michal M, Petersson F (2020) (Mammary Analogue) Secretory carcinoma of the nasal cavity: report of a rare case with p63 and DOG1 expression and uncommon exon 4-Exon 14 ETV6-NTRK3 fusion diagnosed with next generation sequencing. Head Neck Pathol 14(2):542–549. https://doi.org/10.1007/s12105-019-01051-zCrossRefPubMed

23.

Sharma P, Sivakumar N, Pandiar D (2022) Diagnostic accuracy of pan-TRK immunohistochemistry in differentiating secretory carcinoma from acinic cell carcinoma of salivary gland-a systematic review. J Oral Pathol Med. https://doi.org/10.1111/jop.13373. (Epub ahead of print. PMID: 36207812)CrossRefPubMed

24.

Sivakumar N, Narwal A, Pandiar D, Devi A, Anand R, Bansal D, Kamboj M (2022) Diagnostic utility of p63/p40 in the histologic differentiation of salivary gland tumors: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 133(2):189–198. https://doi.org/10.1016/j.oooo.2021.07.010. (Epub 2021 Jul 21 PMID: 34518135)CrossRefPubMed

25.

Takabatake K, Nakano K, Kawai H, Yoshida S, Omori H, Oo MW, Qiusheng S, Uchida K, Mishima K, Nagatsuka H (2020) Secretory carcinoma of salivary gland with high-grade histology arising in hard palate: a case report. Reports 3(2):6. https://doi.org/10.3390/reports3020006CrossRef

26.

Pinto A, Nosé V, Rojas C, Fan YS, Gomez-Fernandez C (2014) Searching for mammary analogue secretory carcinoma of salivary gland among its mimics. Mod Pathol 27(1):30–37. https://doi.org/10.1038/modpathol.2013.84. (Epub 2013 Jun 28. Erratum in: Mod Pathol. 2014 Jun;27(6):918. PMID: 23807775)CrossRefPubMed

27.

Solomon JP, Linkov I, Rosado A, Mullaney K, Rosen EY, Frosina D, Jungbluth AA, Zehir A, Benayed R, Drilon A, Hyman DM, Ladanyi M, Sireci AN, Hechtman JF (2020) NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod Pathol 33(1):38–46. https://doi.org/10.1038/s41379-019-0324-7. (Epub 2019 Aug 2. PMID: 31375766; PMCID: PMC7437403)CrossRefPubMed

28.

Bishop JA, Yonescu R, Batista D, Eisele DW, Westra WH (2013) Most nonparotid “acinic cell carcinomas” represent mammary analog secretory carcinomas. Am J Surg Pathol 37(7):1053–1057. https://doi.org/10.1097/PAS.0b013e3182841554.PMID:23681074;PMCID:PMC3686973CrossRefPubMedPubMedCentral

29.

Serrano-Arévalo ML, Mosqueda-Taylor A, Domínguez-Malagón H, Michal M (2015) Mammary analogue secretory carcinoma (MASC) of salivary gland in four Mexican patients. Med Oral Patol Oral Cir Bucal 20(1):e23–e29. https://doi.org/10.4317/medoral.19874.PMID:25481229;PMCID:PMC4320417CrossRefPubMed

30.

Ohtomo R, Mori T, Shibata S, Tsuta K, Maeshima AM, Akazawa C, Watabe Y, Honda K, Yamada T, Yoshimoto S, Asai M, Okano H, Kanai Y, Tsuda H (2013) SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod Pathol 26(8):1041–1050. https://doi.org/10.1038/modpathol.2013.54. (Epub 2013 Apr 5 PMID: 23558573)CrossRefPubMed

31.

Hsieh MS, Lee YH, Chang YL (2016) SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. Hum Pathol 56:134–142. https://doi.org/10.1016/j.humpath.2016.05.021. (Epub 2016 Jun 17 PMID: 27327192)CrossRefPubMed

32.

Miettinen M, Wang ZF, Lasota J (2009) DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol 33(9):1401–1408. https://doi.org/10.1097/PAS.0b013e3181a90e1a. (PMID: 19606013)CrossRefPubMed

33.

Bell D, Ferrarotto R, Liang L, Goepfert RP, Li J, Ning J, Broaddus R, Weber RS, El-Naggar AK (2020) Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland. Virchows Arch 476(2):295–305. https://doi.org/10.1007/s00428-019-02640-7. (Epub 2019 Aug 19 PMID: 31423558)CrossRefPubMed

Titel: Diagnostic Utility of Expression Pattern of S100/Mammaglobin/SOX10/DOG 1 Immunohistochemistry in Differentiation of Secretory and Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis
verfasst von: Gitika Sharma
Mala Kamboj
Anjali Narwal
R. Keerthika
Anju Devi
Gopikrishnan Vijayakumar
Publikationsdatum: 14.08.2023
Verlag: Springer India
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 1/2024
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-023-04127-z

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Diagnostic Utility of Expression Pattern of S100/Mammaglobin/SOX10/DOG 1 Immunohistochemistry in Differentiation of Secretory and Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis

Abstract

Neu im Fachgebiet HNO

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Nur selten Nachblutungen nach Abszesstonsillektomie

Rezidivierender Peritonsillarabszess nach Oralsex

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

A Novel and Simple Technique to Reduce the Rate of Pharyngocutaneous Fistula Formation Following a Total Laryngectomy - our Initial Results

Rare Case of Squamous Cell Carcinoma of Midline Dorsum of Tongue: Diagnostic and Management Dilemma

The Clipped Wings of “Jatayu”- A Double Set of Bilateral Sequential Bipedicled Flaps to Primarily Close the Secondary Defects on the Back Following the Harvest of a Trapezius Myo-cutaneous Flap

A Study on Morphometric Changes of the Pinna Following Ear Surgery

Giant Pleomorphic Adenoma of Submandibular Gland

Inverted Follicular Keratosis: A Rare Presentation in External Ear Canal

Neu im Fachgebiet HNO

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Nur selten Nachblutungen nach Abszesstonsillektomie

Rezidivierender Peritonsillarabszess nach Oralsex

Update HNO